These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 32027935

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Homoarginine in patients with primary hyperparathyroidism.
    Tomaschitz A, Verheyen N, Gaksch M, Meinitzer A, Pieske B, Kraigher-Krainer E, Colantonio C, März W, Schmidt A, Belyavskiy E, Rus-Machan J, van Ballegooijen AJ, Stiegler C, Amrein K, Ritz E, Fahrleitner-Pammer A, Pilz S.
    Am J Med Sci; 2015 Apr; 349(4):306-11. PubMed ID: 25647833
    [Abstract] [Full Text] [Related]

  • 23. Seasonal changes in serum calcium, PTH and vitamin D levels in patients with primary hyperparathyroidism.
    Nevo-Shor A, Kogan S, Joshua BZ, Bahat-Dinur A, Novack V, Fraenkel M.
    Bone; 2016 Aug; 89():59-63. PubMed ID: 27260647
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The impact of baseline intact parathyroid hormone levels on severity of primary hyperparathyroidism and outcomes in patients undergoing surgery.
    Kandil E, Alabbas H, Tufaro AP, Carson KA, Tufano RP.
    Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):147-50. PubMed ID: 20157060
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism.
    Inoue Y, Kaji H, Hisa I, Tobimatsu T, Naito J, Iu MF, Sugimoto T, Chihara K.
    Endocr J; 2008 Mar; 55(1):57-65. PubMed ID: 18187872
    [Abstract] [Full Text] [Related]

  • 29. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
    Rejnmark L, Amstrup AK, Mollerup CL, Heickendorff L, Mosekilde L.
    J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
    [Abstract] [Full Text] [Related]

  • 30. 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism.
    Christensen MH, Apalset EM, Nordbø Y, Varhaug JE, Mellgren G, Lien EA.
    PLoS One; 2013 Jan; 8(2):e56019. PubMed ID: 23418495
    [Abstract] [Full Text] [Related]

  • 31. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
    Shah VN, Shah CS, Bhadada SK, Rao DS.
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
    [Abstract] [Full Text] [Related]

  • 32. Intact parathyroid hormone levels and primary hyperparathyroidism.
    Al-Hraishawi H, Dellatore PJ, Cai X, Wang X.
    Endocr Res; 2017 Aug; 42(3):241-245. PubMed ID: 28318329
    [Abstract] [Full Text] [Related]

  • 33. Hypovitaminosis D and secondary hyperparathyroidism in resident physicians of a general hospital in southern Brazil.
    Premaor MO, Paludo P, Manica D, Paludo AP, Rossatto ER, Scalco R, Furlanetto TW.
    J Endocrinol Invest; 2008 Nov; 31(11):991-5. PubMed ID: 19169055
    [Abstract] [Full Text] [Related]

  • 34. Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions.
    Fillée C, Keller T, Mourad M, Brinkmann T, Ketelslegers JM.
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):785-9. PubMed ID: 22066864
    [Abstract] [Full Text] [Related]

  • 35. Vitamin D status in primary hyperparathyroidism.
    Saliba W, Lavi I, Rennert HS, Rennert G.
    Eur J Intern Med; 2012 Jan; 23(1):88-92. PubMed ID: 22153538
    [Abstract] [Full Text] [Related]

  • 36. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.
    Viccica G, Cetani F, Vignali E, Miccoli M, Marcocci C.
    Endocrine; 2017 Jan; 55(1):256-265. PubMed ID: 27033542
    [Abstract] [Full Text] [Related]

  • 37. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
    Lee JH, Kim JH, Hong AR, Kim SW, Shin CS.
    Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978
    [Abstract] [Full Text] [Related]

  • 38. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [Abstract] [Full Text] [Related]

  • 39. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
    Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC.
    J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
    [Abstract] [Full Text] [Related]

  • 40. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls.
    Cheng S, Tylavsky F, Kröger H, Kärkkäinen M, Lyytikäinen A, Koistinen A, Mahonen A, Alen M, Halleen J, Väänänen K, Lamberg-Allardt C.
    Am J Clin Nutr; 2003 Sep; 78(3):485-92. PubMed ID: 12936933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.